论文部分内容阅读
进入低增长期的北京药品零售市场,一线连锁或优先维稳、或逆势扩张,二线军团则频频发力于资本运作,为未来的市场变化平添了更多可能性。在历年中国药店排行榜中,入围百强的北京企业有“四大家族”——同仁堂、金象、医保全新、嘉事堂以及好得快、德威治、京卫元华等企业,单店榜有同仁堂、金象、医保全新等在列,直营店百强则仅有金象上榜——这一方面说明一线市场强大的消费力培育了较多上规模企业,单店产出大;一方面也说明雨露均沾,无绝对强者。这种情况已持续多年,北京的药品零售市场一直相对稳定。
To enter the low-growth pharmaceutical retail market in Beijing, the first-line chain or priority maintenance stability, or contrarian expansion, the second legion is frequently devoted to capital operation, adding more possibilities for future market changes. In the history of the Chinese pharmacy list, the top 100 Beijing enterprises have “four families” - Tong Ren Tang, the elephant, Medicare brand new, Chia-chieh Hall and good fast, Dwayne, Jingwei Yuanhua and other enterprises , Single store list Tong Ren Tang, Golden Elephant, Medicare brand new in the column, the top 100 franchise stores only gold Elephant list - on the one hand that the front-line market a strong consumer power to cultivate more on the scale of enterprises, single store Large output; on the one hand also shows that rain are James, there is absolutely no strong. This situation has lasted for many years, and Beijing’s pharmaceutical retail market has been relatively stable.